Illumina Receives New Coverage from Analysts at Tigress Financial (ILMN)
Stock analysts at Tigress Financial began coverage on shares of Illumina (NASDAQ:ILMN) in a report issued on Friday, TheFlyOnTheWall.com reports. The firm set a “buy” rating on the stock.
Shares of Illumina (NASDAQ:ILMN) opened at 160.87 on Friday. Illumina has a 52-week low of $72.77 and a 52-week high of $185.00. The stock has a 50-day moving average of $172.4 and a 200-day moving average of $157.9. The company has a market cap of $21.007 billion and a price-to-earnings ratio of 106.82.
Illumina (NASDAQ:ILMN) last released its earnings data on Wednesday, July 23rd. The company reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.07. The company had revenue of $448.00 million for the quarter, compared to the consensus estimate of $426.50 million. During the same quarter in the previous year, the company posted $0.43 earnings per share. The company’s revenue for the quarter was up 29.5% on a year-over-year basis. On average, analysts predict that Illumina will post $2.29 earnings per share for the current fiscal year.
Other equities research analysts have also recently issued reports about the stock. Analysts at Credit Suisse reiterated an “outperform” rating on shares of Illumina in a research note on Thursday, July 24th. They now have a $198.00 price target on the stock, up previously from $180.00. Separately, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Illumina in a research note on Thursday, July 24th. They now have a $230.00 price target on the stock, up previously from $190.00. Finally, analysts at Macquarie reiterated an “outperform” rating on shares of Illumina in a research note on Thursday, July 24th. They now have a $200.00 price target on the stock, up previously from $177.00. Six equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $170.58.
In other Illumina news, SVP Christian O. Henry sold 10,000 shares of the stock on the open market in a transaction that occurred on Tuesday, July 29th. The stock was sold at an average price of $167.40, for a total value of $1,674,000.00. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.